Evolus (EOLS) EBITDA Margin (2019 - 2026)
Evolus (EOLS) reported EBITDA Margin of 14.76% for Q1 2026, up 1271.0% on a YoY basis from 1.08% in Q1 2025, and down 12108.55% quarter-over-quarter from 0.12% in Q4 2025.
Evolus (EOLS) EBITDA Margin (2019 - 2026) Analysis & Trends
Evolus has reported EBITDA Margin for 8 years, with the latest figure at 14.76% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 1271.0% year-over-year to 14.76%; the trailing twelve-month figure through Mar 2026 stood at 14.2% (up 630.0% YoY), and the FY2025 full-year result was 17.13%, up 199.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 14.76%, down from 0.12% in the prior quarter.
- The five-year high for EBITDA Margin was 0.12% in Q4 2025, with the low at 63.32% in Q2 2022.
- Historically, EBITDA Margin has averaged 29.4% across 5 years, with a median of 27.47% in 2025.
- Annual changes were most pronounced in 2022 — EBITDA Margin tumbled 10421 bps — and 2023, when it jumped 2646 bps.
- Evolus' EBITDA Margin stood at 30.09% in 2022, then jumped by 37 bps to 19.1% in 2023, then jumped by 54 bps to 8.88% in 2024, then soared by 101 bps to 0.12% in 2025, then plunged by 12109 bps to 14.76% in 2026.
- The last three EBITDA Margin figures came in at 14.76% (Q1 2026), 0.12% (Q4 2025), and 22.15% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | -14.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.76% |
| Dec 31, 2025 | 0.12% |
| Sep 30, 2025 | -22.15% |
| Jun 30, 2025 | -24.36% |
| Mar 31, 2025 | -27.47% |
| Dec 31, 2024 | -8.88% |
| Sep 30, 2024 | -31.53% |
| Jun 30, 2024 | -17.03% |
| Mar 31, 2024 | -22.31% |
| Dec 31, 2023 | -19.10% |
| Sep 30, 2023 | -34.11% |
| Jun 30, 2023 | -36.87% |
| Mar 31, 2023 | -35.64% |
| Dec 31, 2022 | -30.09% |
| Sep 30, 2022 | -60.41% |
| Jun 30, 2022 | -63.32% |
| Mar 31, 2022 | -51.92% |
| Dec 31, 2021 | -52.45% |
| Sep 30, 2021 | -72.85% |
| Jun 30, 2021 | -59.78% |